Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Altimmune, Inc. - Common Stock (NQ:ALT)

5.640 +0.140 (+2.55%)
Streaming Delayed Price Updated: 12:42 PM EDT, May 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 699,471
Open 5.510
Bid (Size) 5.630 (8)
Ask (Size) 5.650 (7)
Prev. Close 5.500
Today's Range 5.405 - 5.640
52wk Range 3.553 - 11.16
Shares Outstanding 77,825,450
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Altimmune Reports Better-Than-Feared Q1 Loss, Secures $100M Credit Facility: Retail’s Pleased
In the second quarter, the firm expects to announce data from a phase 2 trial of its investigational therapy, Pemvidutide, in treating metabolic dysfunction-associated steatohepatitis (MASH). 
Via Stocktwits
What to Expect from Altimmune's Earnings
Via Benzinga

Performance

YTD
-20.7%
-20.7%
1 Month
+17.7%
+17.7%
3 Month
-13.0%
-13.0%
6 Month
-21.1%
-21.1%
1 Year
-29.9%
-29.9%

More News

Read More
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
What's Going On With Altimmune (ALT) Stock Today?
Via Benzinga
Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?
Via The Motley Fool
Altimmune Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
Altimmune Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Via Benzinga
Earnings Scheduled For May 13, 2025
Via Benzinga
What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday?
Via Benzinga
8 Analysts Assess Altimmune: What You Need To Know
Via Benzinga
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move
Via The Motley Fool
Altimmune Shares Sink This Year, But Retail Traders See A Buyout On The Horizon
Via Stocktwits
Altimmune Expands Weight-Loss Drug Pemvidutide's Potential To Alcohol-Related Disorders
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
This CoStar Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
Altimmune Retail Buzz Heats Up On MASH Progress, FDA Nod For New Trials: Stock Jumps After Q4 Print
Via Stocktwits
Exposures Product Safety
This Levi Strauss Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
Mastering Market Chaos: StoryTrading’s Top 5 Stocks You Can’t Ignore
Via Talk Markets
Topics Stocks / Equities
Pure Storage Posts Upbeat Results, Joins Cross Country Healthcare, Marvell Technology, Stoke Therapeutics And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Tyson Foods Posts Better-Than-Expected Earnings, Joins Shopify, Sea, Buckle And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
This Nvidia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
MarketBeat Week in Review – 11/4 - 11/8
Via MarketBeat
Topics Economy Government
Exposures Interest Rates Political
How Altimmune Could Grab a Big Chunk of the GLP-1 Market
Via MarketBeat

Frequently Asked Questions

Is Altimmune, Inc. - Common Stock publicly traded?
Yes, Altimmune, Inc. - Common Stock is publicly traded.
What exchange does Altimmune, Inc. - Common Stock trade on?
Altimmune, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Altimmune, Inc. - Common Stock?
The ticker symbol for Altimmune, Inc. - Common Stock is ALT on the Nasdaq Stock Market
What is the current price of Altimmune, Inc. - Common Stock?
The current price of Altimmune, Inc. - Common Stock is 5.640
When was Altimmune, Inc. - Common Stock last traded?
The last trade of Altimmune, Inc. - Common Stock was at 05/20/25 12:42 PM ET
What is the market capitalization of Altimmune, Inc. - Common Stock?
The market capitalization of Altimmune, Inc. - Common Stock is 438.94M
How many shares of Altimmune, Inc. - Common Stock are outstanding?
Altimmune, Inc. - Common Stock has 439M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.